CLINICAL AND SUBCLINICAL CHARACTERISTICS AND RISK FACTORS FOR RELAPSE IN PATIENTS WITH NEPHROTIC SYNDROME AT CAN THO CHILDREN HOSPITAL

Ngoc Rang Nguyen 1,, Thi Tuyet Trinh Nguyen 1
1 Can Tho University of Medicine and Pharmacy

Main Article Content

Abstract

Background: Nephrotic syndrome (NS) is a less frequent disease in children but often relapse after prednisolone treatment. The purpose of this study was to describe clinical and paraclinical characteristics and identify risk factors for relapse in children with NS. Materials and methods: A cohort study of 70 pediatric patients at Can Tho Children Hospital from January 1st, 2019 to June 30th, 2020. Using univariate and multivariate proportional hazard analysis to identify the risk factors for relapse in patients with NS. Results: A total of 70 patients with NS were admitted to the hospital, the median age was 7.0 (4.7-11) years old, male gender accounted for 71.4% (50/70). The median follow-up time was 7.2 (2.2-11.8) months. Relapses were occurred in 20 patients (28.5%). There were 4 independent risk factors for relapses: age group ≤ 5 (Hazard ratio (HR) and 95% confidence interval (CI), 4.31 (1.28-14.52); proteinuria/24 hours > 3g / L, HR = 5.69 (95% CI: 1.41-22.83); Blood cholesterol> 10.6 mmol / L, HR = 3.89 (95% CI 1.15 -13.13) and blood creatinine > 91 µmol / L, HR = 102.6 (95% CI: 5.04-2089). Conclusion: A high serum level of cholesterol and creatinine, a high level of proteinuria and young age at onset increased the relapse rate in children with nephrotic syndrome


 

Article Details

References

1. Lê Nam Trà và Nguyễn Ngọc Sáng (2013), Hội chứng thận hư kháng thuốc steroid, Sách giáo khoa Nhi khoa Nhà xuất bản học Hà Nội, tr. 1150-1160.
2. Dias C B, Pinheiro C C, Santos Silva V D, Hagemann R, Barros R T, Viktoria Woronik Clinics (Sao Paulo) (2012), Proteinuria predicts relapse in adolescent and adult minimal change disease, Viktoria Woronik Clinics, 67 (11), pp. 1271-1274.
3. Eddy AA, Symons JM. (2003), Nephrotic syndrome in childhood, Lancet, 362 (9384), pp. 629-639.
4. Esezobor CI, Ladapo TA, Lesi FE. (2016), Frequency of relapse among Nigerian children with steroid-sensitive nephrotic syndrome, Niger J Clin Pract, 19 (2), pp. 254-8.
5. Gitimu et al. (2016), Paediatric and Young Adults Reference Values for Renal, Cardiac and Pancreatic Function Tests for the Population of Taita Taveta County, Biochem Anal Biochem, 5:3.
6. Jellouli M, Brika M, Abidi K, Ferjani M, Naija O, Hammi Y, Gargah T. (2016), Nephrotic syndrome in children: risk factors for steroid dependence, Tunis Med, 94 (7), pp. 401-405.
7. KDIGO Clinical Practice Guideline for Glomerulonephritis. Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. Kidney Int Suppl. 2012; (2):139–274.
8. Lawang S A, Syarifuddin Rauf, J. S. Lisal, Husein Albar, Dasril Daud. (2008), Plasma lipids as risk factors in relapsing nephrotic syndrome, Paediatrica Indonesiana, Vol 48, N0 6.
9. Mahmud S, Jahan S, Hossain MM. (2011), Hyperlipidemia in childhood idiopathic nephrotic syndrome during initial remission and relapse, Mymensingh Med J. 2011, 20 (3), pp. 402-6.
10. Noer MS. (2005), Predictors of relapse in steroid-sensitive nephrotic syndrome, Southeast Asian J Trop Med Public Health, 36 (5), pp. 1313-20.
11. Pandey J C and Prasad C K. (2016), Lipid Profile Abnormalities in Nephrotic Syndrome Asian, Journal of Biomedical and Pharmaceutical Sciences, 6 (54), pp. 17-19.
12. Sarker et al. (2012), Risk Factor for Relapse in Childhood Nephrotic Syndrome - A Hospital Based Retrospective Study, Faridpur Med. Coll. J., 7 (1), pp. 18-22.
13. Sureshkumar P, Hodson EM, Willis NS, Barzi F, Craig JC. (2014), Predictors of remission and relapse in idiopathic nephrotic syndrome: A prospective cohort study, Pediatr Nephrol 2014, 29, pp. 1039‑46.
14. Takeda A, Matsutani H, Niimura F, Ohgushi H. (1996), Risk factors for relapse in childhood nephrotic syndrome, Pediatr Nephrol, 10 (6), pp. 740-1.
15. Wang S, Pan Q, Xu C et al. (2018), Massive Proteinuria-Induced Injury of Tubular Epithelial Cells in Nephrotic Syndrome is Not Exacerbated by Furosemide, Cell Physiol Biochem, 45 (4), pp. 1700-1706.